Quest PharmaTech Inc (QPT)

TSXV
0.0550
0.0000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.0550/0.0700
  • Day's Range:
    0.0550 - 0.0550

QPT Overview

Prev. Close
0.06
Day's Range
0.055-0.055
Revenue
-
Open
0.055
52 wk Range
0.05-0.165
EPS
-0.514
Volume
0
Market Cap
9.3M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
13,729
P/E Ratio
-0.126
Beta
1.13
1-Year Change
-35.29%
Shares Outstanding
169,129,247
Next Earnings Date
-
What is your sentiment on Quest PharmaTech?
or
Market is currently closed. Voting is open during market hours.

Quest PharmaTech Inc News

Quest PharmaTech Inc Analysis

Quest PharmaTech Inc Company Profile

Quest PharmaTech Inc Company Profile

Employees
0
Market
Canada
  • Type:Equity
  • Market:Canada
  • ISIN:CA74836M1068
  • CUSIP:74836M106

Quest PharmaTech Inc., a pharmaceutical company, develops antibody based immunotherapeutic products for cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, an anti-CA-125 antibody, which has completed Phase II clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer. Further, the company develops products by using proprietary transdermal delivery technologies for dermatology and wound healing applications; skin penetrating active molecules for cosmetic and pharmaceutical use; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell